{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:40:46Z","timestamp":1782603646634,"version":"3.54.5"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1007\/s10741-007-9002-9","type":"journal-article","created":{"date-parts":[[2007,3,7]],"date-time":"2007-03-07T17:16:59Z","timestamp":1173287819000},"page":"23-36","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions"],"prefix":"10.1007","volume":"12","author":[{"given":"Michael A.","family":"Burke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Cotts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,3,8]]},"reference":[{"key":"9002_CR1","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1378\/chest.114.5.1283","volume":"114","author":"C Lok","year":"1998","unstructured":"Lok C, Morgan C, Ranganathan N (1998) The accuracy and interobserver agreement in detecting the \u2018gallop sounds\u2019 by cardiac auscultation. Chest 114:1283\u20131288","journal-title":"Chest"},{"key":"9002_CR2","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/0735-1097(93)90405-P","volume":"22","author":"S Butman","year":"1993","unstructured":"Butman S, Ewy G, Standen J, Kern K, Hahn E (1993) Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distention. J Am Coll Cardiol 22:968\u2013974","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ejheart.2004.08.002","volume":"6","author":"C Fonseca","year":"2004","unstructured":"Fonseca C, Morais H, Mota T et al (2004) The diagnosis of heart failure in primary care: value of signs and symptoms. Eur J Heart Fail 6:795\u2013800","journal-title":"Eur J Heart Fail"},{"key":"9002_CR4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0735-1097(00)01156-6","volume":"37","author":"Q Dao","year":"2001","unstructured":"Dao Q, Krishnaswamy P, Kazanegra R et al (2001) Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 37:379\u2013385","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMoa020233","volume":"347","author":"A Maisel","year":"2002","unstructured":"Maisel A, Krishnaswamy P, Nowak R et al (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161\u2013167","journal-title":"N Engl J Med"},{"key":"9002_CR6","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.amjcard.2004.12.032","volume":"95","author":"J Januzzi","year":"2005","unstructured":"Januzzi J, Camargo C, Anwaruddin S et al (2005) The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. Am J Cardiol 95:948\u2013954","journal-title":"Am J Cardiol"},{"key":"9002_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-5299.2004.03271.x","volume":"10","author":"M Silver","year":"2004","unstructured":"Silver M, Maisel A, Yancy C et al (2004) BNP Consensus Panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail 10:1\u201330","journal-title":"Congest Heart Fail"},{"key":"9002_CR8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/pcad.2002.24599","volume":"44","author":"M Cowie","year":"2002","unstructured":"Cowie M, Mendez G (2002) BNP and congestive heart failure. Prog Cardiovasc Dis 44:293\u2013321","journal-title":"Prog Cardiovasc Dis"},{"key":"9002_CR9","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1378\/chest.125.2.652","volume":"125","author":"S de Denus","year":"2004","unstructured":"de Denus S, Pharand C, Williamson D (2004) Brain natriuretic peptide levels in the management of heart failure: the versatile neurohormone. Chest 125:652\u2013668","journal-title":"Chest"},{"key":"9002_CR10","first-page":"740","volume":"44","author":"R Rodeheffer","year":"2004","unstructured":"Rodeheffer R (2004) Measuring plasma B-type natriuretic peptide in heart failure: good to go in 2004? J Am Coll Cardiol 44:740\u2013749","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR11","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1373\/clinchem.2005.061770","volume":"6","author":"I Giuliani","year":"2006","unstructured":"Giuliani I, Rieunier F, Larue C et al (2006) Assay for measurement of intact B-Type natriuretic peptide prohormone in blood. Clin Chem 6:1054\u20131061","journal-title":"Clin Chem"},{"key":"9002_CR12","first-page":"H1684","volume":"274","author":"A Luchner","year":"1998","unstructured":"Luchner A, Stevens T, Borgeson D et al (1998) Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol 274:H1684\u2013H1689","journal-title":"Am J Physiol"},{"key":"9002_CR13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0008-6363(01)00316-9","volume":"51","author":"A Luchner","year":"2001","unstructured":"Luchner A, Muders F, Dietl O et al (2001) Differential expression of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction. Cardiovasc Res 51:601\u2013607","journal-title":"Cardiovasc Res"},{"key":"9002_CR14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/01.CIR.90.1.195","volume":"90","author":"H Yasue","year":"1994","unstructured":"Yasue H, Yoshimura M, Sumida H et al (1994) Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90:195\u2013203","journal-title":"Circulation"},{"key":"9002_CR15","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1067\/mhj.2003.152","volume":"145","author":"K Adams","year":"2003","unstructured":"Adams K, Mathur V, Gheorghiade M (2003) B-type natriuretic peptide: From bench to bedside. Am Heart J 145:S34\u2013S46","journal-title":"Am Heart J"},{"key":"9002_CR16","doi-asserted-by":"crossref","first-page":"28050","DOI":"10.1074\/jbc.272.44.28050","volume":"272","author":"F Liang","year":"1997","unstructured":"Liang F, Wu J, Garami M, Gardner D (1997) Mechanical strain increases expression of the brain natriuretic peptide gene in rat cardiac myocytes. J Biol Chem 272:28050\u201328056","journal-title":"J Biol Chem"},{"key":"9002_CR17","doi-asserted-by":"crossref","first-page":"14612","DOI":"10.1074\/jbc.273.23.14612","volume":"273","author":"F Liang","year":"1998","unstructured":"Liang F, Gardner D (1998) Autocrine\/paracrine determinants of strain-activated brain natriuretic peptide gene expression in cultured cardiac myocytes. J Biol Chem 273:14612\u201314619","journal-title":"J Biol Chem"},{"key":"9002_CR18","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1172\/JCI7362","volume":"104","author":"F Liang","year":"1999","unstructured":"Liang F, Gardner D (1999) Mechanical strain activates BNP gene transcription through a p38\/NF-kappaB-dependent mechanism. J Clin Invest 104:1603\u20131612","journal-title":"J Clin Invest"},{"key":"9002_CR19","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jacc.2005.11.030","volume":"47","author":"Y Iwanaga","year":"2006","unstructured":"Iwanaga Y, Nishi I, Furuichi S et al (2006) B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 47:742\u2013748","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR20","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1161\/01.CIR.102.25.3074","volume":"102","author":"S Wiese","year":"2000","unstructured":"Wiese S, Breyer T, Dragu A et al (2000) Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length. Circulation 102:3074\u20133079","journal-title":"Circulation"},{"key":"9002_CR21","doi-asserted-by":"crossref","first-page":"E1115","DOI":"10.1152\/ajpendo.2000.278.6.E1115","volume":"278","author":"Q He","year":"2000","unstructured":"He Q, Wu G, LaPointe M (2000) Isoproterenol and cAMP regulation of the human brain natriuretic peptide gene involves Src and Rac. Am J Physiol Endocrinol Metab 278:E1115\u2013E1123","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9002_CR22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1472-8206.2005.00336.x","volume":"19","author":"A Houben","year":"2005","unstructured":"Houben A, van der Zander K, de Leeuw P (2005) Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology. Fundam Clin Pharmacol 19:411\u2013419","journal-title":"Fundam Clin Pharmacol"},{"key":"9002_CR23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.tem.2005.10.007","volume":"16","author":"MF McGrath","year":"2005","unstructured":"McGrath MF, Kuroski de Bold ML, de Bold AJ (2005) The endocrine function of the heart. Trends Endocrinol Metab 16:469\u2013477","journal-title":"Trends Endocrinol Metab"},{"key":"9002_CR24","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0002-9149(03)00741-0","volume":"92","author":"A Wu","year":"2003","unstructured":"Wu A, Smith A, Wieczorek S et al (2003) Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 92:628\u2013631","journal-title":"Am J Cardiol"},{"key":"9002_CR25","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1373\/clinchem.2004.038752","volume":"50","author":"S Bruins","year":"2004","unstructured":"Bruins S, Fokkema M, R\u00f6mer J et al (2004) High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem 50:2052\u20132058","journal-title":"Clin Chem"},{"key":"9002_CR26","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0735-1097(02)02059-4","volume":"40","author":"M Redfield","year":"2002","unstructured":"Redfield M, Rodeheffer R, Jacobsen S, Mahoney D, Bailey K, Burnett J (2002) Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40:976\u2013982","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR27","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ahj.2004.01.013","volume":"147","author":"AS Maisel","year":"2004","unstructured":"Maisel AS, Clopton P, Krishnaswamy P et al (2004) Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: Results from the Breathing Not Properly (BNP) multinational study. Am Heart J 147:1078\u20131084","journal-title":"Am Heart J"},{"key":"9002_CR28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2796.2005.01503.x","volume":"258","author":"C Mueller","year":"2005","unstructured":"Mueller C, Laule-Kilian K, Frana B et al (2005) The use of B-type natriuretic peptide in the management of elderly patients with acute dyspnea. J Intern Med 258:77\u201385","journal-title":"J Intern Med"},{"key":"9002_CR29","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ahj.2005.04.004","volume":"151","author":"P Berdagu\u00e9","year":"2006","unstructured":"Berdagu\u00e9 P, Caffin P, Barazer I et al (2006) Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients. Am Heart J 151:690\u2013698","journal-title":"Am Heart J"},{"key":"9002_CR30","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1001\/archinte.164.20.2247","volume":"164","author":"J McCord","year":"2004","unstructured":"McCord J, Mundy B, Hudson M et al (2004) Relationship between obesity and B-type natriuretic peptide levels. Arch Intern Med 164:2247\u20132252","journal-title":"Arch Intern Med"},{"key":"9002_CR31","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.ahj.2005.10.011","volume":"151","author":"LB Daniels","year":"2006","unstructured":"Daniels LB, Clopton P, Bhalla V et al (2006) How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure: Results from the Breathing Not Properly Multinational Study. Am Heart J 151:999\u20131005","journal-title":"Am Heart J"},{"key":"9002_CR32","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ahj.2004.07.010","volume":"149","author":"D Krauser","year":"2005","unstructured":"Krauser D, Lloyd-Jones D, Chae C et al (2005) Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J 149:744\u2013750","journal-title":"Am Heart J"},{"key":"9002_CR33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.CIR.0000081657.83724.A7","volume":"108","author":"TJ Wang","year":"2003","unstructured":"Wang TJ, Larson MG, Levy D et al (2003) Heritability and genetic linkage of plasma natriuretic peptide levels. Circulation 108:13\u201316","journal-title":"Circulation"},{"key":"9002_CR34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1507\/endocrj.52.11","volume":"52","author":"T Nakayama","year":"2005","unstructured":"Nakayama T (2005) The genetic contribution of the natriuretic peptide system to cardiovascular diseases. Endocr J 52:11\u201321","journal-title":"Endocr J"},{"key":"9002_CR35","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jacc.2003.08.046","volume":"43","author":"R Troughton","year":"2004","unstructured":"Troughton R, Prior D, Pereira J et al (2004) Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol 43:416\u2013422","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1023\/B:HREV.0000046364.68371.b0","volume":"9","author":"L Yap","year":"2004","unstructured":"Yap L (2004) B-type natriuretic peptides and the right heart. Heart Fail Rev 9:99\u2013105","journal-title":"Heart Fail Rev"},{"key":"9002_CR37","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1042\/CS20050336","volume":"110","author":"E Pedersen","year":"2006","unstructured":"Pedersen E, Bacevicius E, Bech J, Solling K, Pedersen H (2006) Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in chronic renal failure. Clin Sci 110:491\u2013501","journal-title":"Clin Sci"},{"key":"9002_CR38","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.annemergmed.2005.01.027","volume":"45","author":"CW Knudsen","year":"2005","unstructured":"Knudsen CW, Clopton P, Westheim A et al (2005) Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: an analysis from the Breathing Not Properly Multinational Study. Ann Emerg Med 45:573\u2013580","journal-title":"Ann Emerg Med"},{"key":"9002_CR39","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/hrt.2004.037762","volume":"91","author":"T Mueller","year":"2005","unstructured":"Mueller T, Gegenhuber A, Poelz W, Haltmayer M (2005) Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart 91:606\u2013612","journal-title":"Heart"},{"key":"9002_CR40","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/archinte.164.18.1978","volume":"164","author":"J Doust","year":"2004","unstructured":"Doust J, Glasziou P, Pietrzak E, Dobson A (2004) A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 164:1978\u20131984","journal-title":"Arch Intern Med"},{"key":"9002_CR41","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ejheart.2005.10.004","volume":"4","author":"J Latour-P\u00e9rez","year":"2006","unstructured":"Latour-P\u00e9rez J, Coves-Orts FJ, Abad-Terrado C, Abraira V, Zamora J (2006) Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: a systematic review. Eur J Heart Fail 4:390\u2013399","journal-title":"Eur J Heart Fail"},{"key":"9002_CR42","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.jacc.2004.06.015","volume":"2004","author":"A Maisel","year":"2004","unstructured":"Maisel A, Hollander J, Guss D et al (2004) Primary results of the rapid emergency department heart failure outpatient trial (REDHOT). J Am Coll Cardiol 2004:1328\u20131333","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR43","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ahj.2005.10.017","volume":"151","author":"CK Brenden","year":"2006","unstructured":"Brenden CK, Hollander JE, Guss D et al (2006) Gray zone BNP levels in heart failure patients in the emergency department: Results from the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) multicenter study. Am Heart J 151:1013\u20131018","journal-title":"Am Heart J"},{"key":"9002_CR44","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJMoa031681","volume":"350","author":"C Mueller","year":"2004","unstructured":"Mueller C, Scholer A, Laule-Kilian K et al (2004) Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350:647\u2013654","journal-title":"N Engl J Med"},{"key":"9002_CR45","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/bmj.330.7492.625","volume":"330","author":"J Doust","year":"2005","unstructured":"Doust J, Pietrzak E, Dobson A, Glasziou P (2005) How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. Br Med J 330:625","journal-title":"Br Med J"},{"key":"9002_CR46","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1161\/01.CIR.0000057980.84624.95","volume":"107","author":"B Vrtovec","year":"2003","unstructured":"Vrtovec B, Delgado R, Zewail A, Thomas C, Richartz B, Radovancevic B (2003) Prolonged QTc and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure. Circulation 107:1764\u20131769","journal-title":"Circulation"},{"key":"9002_CR47","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ehj.2003.10.030","volume":"25","author":"R Latini","year":"2004","unstructured":"Latini R, Masson S, Anand I et al (2004) The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J 25:292\u2013299","journal-title":"Eur Heart J"},{"key":"9002_CR48","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0735-1097(00)00912-8","volume":"36","author":"K Maeda","year":"2000","unstructured":"Maeda K, Tsutamoto T, Wada A et al (2000) High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 36:1587\u20131593","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR49","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0735-1097(01)01383-3","volume":"38","author":"B Stanek","year":"2001","unstructured":"Stanek B, Frey B, H\u00fclsmann M et al (2001) Prognostic evaluation of neurohumoral plasma levels before and during beta-blockade therapy in advanced left ventricular dysfunction. J Am Coll Cardiol 38:436\u2013442","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR50","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/S0735-1097(01)01672-2","volume":"38","author":"J Koglin","year":"2001","unstructured":"Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, von Schmidt W (2001) Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 38:1934\u20131941","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1067\/mem.2002.121483","volume":"39","author":"A Harrison","year":"2002","unstructured":"Harrison A, Morrison L, Krishnaswamy P et al (2002) B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 39:131\u2013138","journal-title":"Ann Emerg Med"},{"key":"9002_CR52","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0735-1097(01)01269-4","volume":"37","author":"A Richards","year":"2001","unstructured":"Richards A, Doughty R, Nicholls M et al (2001) Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction benefit from carvedilol in chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 37:1781\u20131787","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR53","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ehj.2003.07.005","volume":"24","author":"R Gardner","year":"2003","unstructured":"Gardner R, \u00d6zalp F, Murday A, Robb S, McDonagh T (2003) N-terminal pro-brain natriuretic peptide: a new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 24:1735\u20131743","journal-title":"Eur Heart J"},{"key":"9002_CR54","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacc.2003.09.044","volume":"43","author":"D Logeart","year":"2004","unstructured":"Logeart D, Thabut G, Jourdain P et al (2004) Predischarge B-type natriuretic peptide assay for identifying patients at high risk for re-admission after decompensated heart failure. J Am Coll Cardiol 43:635\u2013641","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR55","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.0000144310.04433.BE","volume":"110","author":"P Bettencourt","year":"2004","unstructured":"Bettencourt P, Azevedo A, Pimenta J, Fri\u00f5es F, Ferreira S, Ferreira A (2004) N-terminal-pro-brain natriuretic peptide predicts outcomes after hospital discharge in heart failure patients. Circulation 110:2168\u20132174","journal-title":"Circulation"},{"key":"9002_CR56","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ejheart.2004.12.006","volume":"7","author":"V Verdiani","year":"2005","unstructured":"Verdiani V, Nozzoli C, Bacci F et al (2005) Pre-discharge B-type natriuretic peptide predicts early recurrence of decompensated heart failure in patients admitted to a general medical unit. Eur J Heart Fail 7:566\u2013571","journal-title":"Eur J Heart Fail"},{"key":"9002_CR57","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1161\/01.CIR.0000143059.68996.A7","volume":"110","author":"F Hartmann","year":"2004","unstructured":"Hartmann F, Packer M, Coats A et al (2004) Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvediolol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation 110:1780\u20131786","journal-title":"Circulation"},{"key":"9002_CR58","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1161\/01.CIR.0000054164.99881.00","volume":"107","author":"I Anand","year":"2003","unstructured":"Anand I, Fisher L, Chiang Y et al (2003) Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107:1278\u20131283","journal-title":"Circulation"},{"key":"9002_CR59","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","volume":"350","author":"T Wang","year":"2004","unstructured":"Wang T, Larson M, Levy D et al (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350:655\u2013663","journal-title":"N Engl J Med"},{"key":"9002_CR60","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/jama.288.10.1252","volume":"288","author":"R Vasan","year":"2002","unstructured":"Vasan R, Benjamin E, Larson M et al (2002) Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction. JAMA 288:1252\u20131259","journal-title":"JAMA"},{"key":"9002_CR61","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1161\/01.CIR.0000130845.38133.8F","volume":"109","author":"M Redfield","year":"2004","unstructured":"Redfield M, Rodeheffer R, Jacobsen S, Mahoney D, Bailey K, Burnett J (2004) Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community based study. Circulation 109:3176\u20133181","journal-title":"Circulation"},{"key":"9002_CR62","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.cardfail.2005.06.436","volume":"11","author":"M Nakamura","year":"2005","unstructured":"Nakamura M, Tanaka F, Sato K et al (2005) B-type natriuretic peptide testing for structural heart disease screening: a general population-based study. J Card Fail 11:705\u2013712","journal-title":"J Card Fail"},{"key":"9002_CR63","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","volume":"289","author":"MM Redfield","year":"2003","unstructured":"Redfield MM, Jacobsen SJ, Burnett JC et al (2003) Burden of systolic and diastolic ventricular dysfunction in the community. JAMA 289:194\u2013202","journal-title":"JAMA"},{"key":"9002_CR64","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.jacc.2004.09.038","volume":"44","author":"M Vanderheyden","year":"2004","unstructured":"Vanderheyden M, Goethals M, Verstreken S et al (2004) Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. J Am Coll Cardiol 44:2349\u20132354","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR65","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/hc0502.103010","volume":"105","author":"E Lubien","year":"2002","unstructured":"Lubien E, DeMaria A, Krishnaswamy P et al (2002) Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with doppler velocity recordings. Circulation 105:595\u2013601","journal-title":"Circulation"},{"key":"9002_CR66","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.amjcard.2004.11.006","volume":"95","author":"S Brucks","year":"2005","unstructured":"Brucks S, Little W, Chao T et al (2005) Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction. Am J Cardiol 95:603\u2013606","journal-title":"Am J Cardiol"},{"key":"9002_CR67","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ahj.2005.02.045","volume":"150","author":"E Arteaga","year":"2005","unstructured":"Arteaga E, Araujo AQ, Buck P et al (2005) Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy. Am Heart J 150:1228\u20131232","journal-title":"Am Heart J"},{"key":"9002_CR68","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.amjcard.2005.08.028","volume":"97","author":"D Conen","year":"2006","unstructured":"Conen D, Zeller A, Pfisterer M, Martina B (2006) Usefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension. Am J Cardiol 97:249\u2013252","journal-title":"Am J Cardiol"},{"key":"9002_CR69","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ejheart.2004.12.010","volume":"7","author":"T Lukowicz","year":"2005","unstructured":"Lukowicz T, Fischer M, Hense H et al (2005) BNP as a marked of diastolic dysfunction in the general population: importance of left ventricular hypertrophy. Eur J Heart Fail 7:525\u2013531","journal-title":"Eur J Heart Fail"},{"key":"9002_CR70","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ejheart.2004.01.005","volume":"6","author":"U Dahlstr\u00f6m","year":"2004","unstructured":"Dahlstr\u00f6m U (2004) Can natriuretic peptides be used for the diagnosis of diastolic heart failure? Eur J Heart Fail 6:281\u2013287","journal-title":"Eur J Heart Fail"},{"key":"9002_CR71","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0735-1097(03)00405-4","volume":"41","author":"AS Maisel","year":"2003","unstructured":"Maisel AS, McCord J, Nowak RM et al (2003) Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction: results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol 41:2010\u20132017","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR72","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cccn.2004.04.004","volume":"346","author":"S Wiviott","year":"2004","unstructured":"Wiviott S, de Lemos J, Morrow D (2004) Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes. Clin Chim Acta 346:119\u2013128","journal-title":"Clin Chim Acta"},{"key":"9002_CR73","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1161\/01.CIR.97.19.1921","volume":"97","author":"A Richards","year":"1998","unstructured":"Richards A, Nicholls M, Yandle T et al (1998) Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 97:1921\u20131929","journal-title":"Circulation"},{"key":"9002_CR74","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJMoa011053","volume":"345","author":"J de Lemos","year":"2001","unstructured":"de Lemos J, Morrow D, Bentley J et al (2001) The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345:1014\u20131021","journal-title":"N Engl J Med"},{"key":"9002_CR75","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9149(01)02271-8","volume":"89","author":"T Omland","year":"2002","unstructured":"Omland T, de Lemos J, Morrow D et al (2002) Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. Am J Cardiol 89:463\u2013465","journal-title":"Am J Cardiol"},{"key":"9002_CR76","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1161\/01.CIR.0000041661.63285.AE","volume":"106","author":"T Omland","year":"2002","unstructured":"Omland T, Persson A, Ng L et al (2002) N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 106:2913\u20132918","journal-title":"Circulation"},{"key":"9002_CR77","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/01.CIR.0000079170.10579.DC","volume":"2003","author":"S James","year":"2003","unstructured":"James S, Lindahl B, Siegbahn A et al (2003) N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable angina coronary artery disease: a Global Utilization of Strategies to Open occluded arteries (GUSTO)-IV substudy. Circulation 2003:275\u2013281","journal-title":"Circulation"},{"key":"9002_CR78","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0735-1097(03)00168-2","volume":"41","author":"D Morrow","year":"2003","unstructured":"Morrow D, de Lemos J, Sabatine M et al (2003) Evaluation of B-type natriuretic peptide for risk assessment in unstable angina\/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol 41:1264\u20131272","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR79","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.jacc.2004.07.057","volume":"44","author":"M Sabatine","year":"2004","unstructured":"Sabatine M, Morrow D, de Lemos J et al (2004) Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 44:1988\u20131995","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR80","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0735-1097(98)00045-X","volume":"31","author":"G Takemura","year":"1998","unstructured":"Takemura G, Takatsu Y, Doyama K et al (1998) Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis. J Am Coll Cardiol 31:254\u2013265","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR81","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/01.CIR.0000068314.02595.B2","volume":"107","author":"G Palladini","year":"2003","unstructured":"Palladini G, Campana C, Klersy C et al (2003) Serum N-terminal Pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation 107:2440\u20132445","journal-title":"Circulation"},{"key":"9002_CR82","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.amjcard.2005.05.057","volume":"96","author":"M Nordlinger","year":"2005","unstructured":"Nordlinger M, Magnani B, Skinner M, Falk R (2005) Is elevated plasma B-natriuretic peptide in amyloidosis simply a function of the presence of heart failure? Am J Cardiol 96:982\u2013984","journal-title":"Am J Cardiol"},{"key":"9002_CR83","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.jacc.2005.03.050","volume":"45","author":"F Leya","year":"2005","unstructured":"Leya F, Arab D, Joyal D et al (2005) The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy. J Am Coll Cardiol 45:1900\u20131902","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR84","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.jacc.2006.01.007","volume":"47","author":"L Babuin","year":"2006","unstructured":"Babuin L, Alegria JR, Oh JK et al (2006) Brain natriuretic peptide levels in constrictive pericarditis and restrictive cardiomyopathy. J Am Coll Cardiol 47:1489\u20131491","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR85","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.amjcard.2003.07.010","volume":"92","author":"H Silvet","year":"2003","unstructured":"Silvet H, Young-Xu Y, Walleigh D, Ravid S (2003) Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol 92:1124\u20131127","journal-title":"Am J Cardiol"},{"key":"9002_CR86","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1071-9164(00)90010-1","volume":"6","author":"S Inoue","year":"2000","unstructured":"Inoue S, Murakami Y, Sano K, Katoh H, Shimada T (2000) Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 6:92\u201396","journal-title":"J Card Fail"},{"key":"9002_CR87","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.amjcard.2004.03.013","volume":"93","author":"B Wozakowska-Kaplon","year":"2004","unstructured":"Wozakowska-Kaplon B (2004) Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation. Am J Cardiol 93:1555\u20131558","journal-title":"Am J Cardiol"},{"key":"9002_CR88","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00392-005-0301-7","volume":"94","author":"DI Shin","year":"2005","unstructured":"Shin DI, Jaekel K, Schley P et al (2005) Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion. Z Kardiol 94:795\u2013800","journal-title":"Z Kardiol"},{"key":"9002_CR89","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.amjcard.2005.12.071","volume":"97","author":"T Yamada","year":"2006","unstructured":"Yamada T, Murakami Y, Okada T et al (2006) Plasma atrial natriuretic peptide and brain natriuretic peptide levels after radiofrequency catheter ablation of atrial fibrillation. Am J Cardiol 97:1741\u20131744","journal-title":"Am J Cardiol"},{"key":"9002_CR90","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1253\/circj.70.100","volume":"70","author":"SH Lee","year":"2006","unstructured":"Lee SH, Jung JH, Choi SH et al (2006) Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation. Circ J 70:100\u2013104","journal-title":"Circ J"},{"key":"9002_CR91","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jacc.2005.05.057","volume":"46","author":"C Knudsen","year":"2005","unstructured":"Knudsen C, Omland T, Clopton P et al (2005) Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients. J Am Coll Cardiol 46:838\u2013844","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR92","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1161\/01.CIR.0000060533.79248.0C","volume":"107","author":"I Gerber","year":"2003","unstructured":"Gerber I, Stewart R, Legget M et al (2003) Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 107:1884\u20131890","journal-title":"Circulation"},{"key":"9002_CR93","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.amjcard.2005.06.092","volume":"96","author":"M Nessmith","year":"2005","unstructured":"Nessmith M, Fukuta H, Brucks S, Little W (2005) Usefulness of an elevated B-type natriuretic peptide in predicting survival in patients with aortic stenosis treated without surgery. Am J Cardiol 96:1445\u20131448","journal-title":"Am J Cardiol"},{"key":"9002_CR94","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.amjcard.2004.05.043","volume":"94","author":"M Eimer","year":"2004","unstructured":"Eimer M, Ekery DL, Rigolin VH et al (2004) Elevated B-type natriuretic peptide in asymptomatic men with chronic aortic regurgitation and preserved left ventricular systolic function. Am J Cardiol 94:676\u2013678","journal-title":"Am J Cardiol"},{"key":"9002_CR95","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/01.CIR.0000164269.80908.9D","volume":"111","author":"D Detaint","year":"2005","unstructured":"Detaint D, Messika-Zeitoun D, Avierinos J et al (2005) B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome. Circulation 111:2391\u20132397","journal-title":"Circulation"},{"key":"9002_CR96","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1540-8175.2005.04085.x","volume":"22","author":"A Arat-Ozkan","year":"2005","unstructured":"Arat-Ozkan A, Kaya A, Yigit Z et al (2005) Serum N-terminal pro-BNP levels correlate with symptoms and echocardiographic findings in patients with mitral stenosis. Echocardiography 22:473\u2013478","journal-title":"Echocardiography"},{"key":"9002_CR97","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1378\/chest.126.4.1330","volume":"126","author":"L Yap","year":"2004","unstructured":"Yap L, Mukerjee D, Timms P, Ashrafian H, Coghlan J (2004) Natriuretic peptides, respiratory disease, and the right heart. Chest 126:1330\u20131336","journal-title":"Chest"},{"key":"9002_CR98","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1197\/aemj.10.3.198","volume":"10","author":"PA McCullough","year":"2003","unstructured":"McCullough PA, Hollander JE, Nowak RM et al (2003) Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med 10:198\u2013204","journal-title":"Acad Emerg Med"},{"key":"9002_CR99","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0735-1097(01)01744-2","volume":"39","author":"LK Morrison","year":"2002","unstructured":"Morrison LK, Harrison A, Krishnaswamy P et al (2002) Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 39:202\u2013209","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR100","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ahj.2005.03.036","volume":"151","author":"C Mueller","year":"2006","unstructured":"Mueller C, Laule-Kilian K, Frana B et al (2006) Use of B-type natriuretic peptide in the management of acute dyspnea in patients with pulmonary disease. Am Heart J 151:471\u2013477","journal-title":"Am Heart J"},{"key":"9002_CR101","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.amjcard.2005.11.075","volume":"97","author":"F Pieralli","year":"2006","unstructured":"Pieralli F, Olivotto I, Vanni S et al (2006) Usefulness of bedside brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism. Am J Cardiol 97:1386\u20131390","journal-title":"Am J Cardiol"},{"key":"9002_CR102","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0002-8703(03)00528-3","volume":"147","author":"S Kruger","year":"2004","unstructured":"Kruger S, Graf J, Merx MW et al (2004) Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. Am Heart J 147:60\u201365","journal-title":"Am Heart J"},{"key":"9002_CR103","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0735-1097(97)00452-X","volume":"31","author":"N Nagaya","year":"1998","unstructured":"Nagaya N, Nishikimi T, Okano Y et al (1998) Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 31:202\u2013208","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR104","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1164\/rccm.200510-1545OC","volume":"173","author":"HH Leuchte","year":"2006","unstructured":"Leuchte HH, Baumgartner RA, Nounou ME et al (2006) Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Resp Crit Care Med 173:744\u2013750","journal-title":"Am J Resp Crit Care Med"},{"key":"9002_CR105","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1378\/chest.129.5.1349","volume":"129","author":"M Maeder","year":"2006","unstructured":"Maeder M, Fehr T, Rickli H, Ammann P (2006) Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 129:1349\u20131366","journal-title":"Chest"},{"key":"9002_CR106","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/cc4883","volume":"10","author":"U Hoffman","year":"2006","unstructured":"Hoffman U, Borggrefe M, Brueckmann M (2006) New horizons: NT-proBNP for risk stratification of patients with shock in the intensive care unit. Crit Care 10:134","journal-title":"Crit Care"},{"key":"9002_CR107","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/01.CCM.0000114827.93410.D8","volume":"32","author":"J Charpentier","year":"2004","unstructured":"Charpentier J, Luyt C, Fulla Y et al (2004) Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 32:660\u2013665","journal-title":"Crit Care Med"},{"key":"9002_CR108","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/01.CCM.0000133694.28370.7F","volume":"32","author":"RH Tung","year":"2004","unstructured":"Tung RH, Garcia C, Morss AM et al (2004) Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med 32:1643\u20131647","journal-title":"Crit Care Med"},{"key":"9002_CR109","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/CIRCULATIONAHA.104.472050","volume":"112","author":"M Brueckmann","year":"2005","unstructured":"Brueckmann M, Huhle G, Lang S et al (2005) Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 112:527\u2013534","journal-title":"Circulation"},{"key":"9002_CR110","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/01.CCM.0000162561.82012.E9","volume":"33","author":"A Roch","year":"2005","unstructured":"Roch A, Allardet-Servent J, Michelet P et al (2005) NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med 33:1001\u20131007","journal-title":"Crit Care Med"},{"key":"9002_CR111","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1186\/cc4839","volume":"10","author":"JL Januzzi","year":"2006","unstructured":"Januzzi JL, Morss A, Tung R et al (2006) Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study. Crit Care 10:R37","journal-title":"Crit Care"},{"key":"9002_CR112","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s00134-003-1910-0","volume":"29","author":"R Witthaut","year":"2003","unstructured":"Witthaut R, Busch C, Fraunberger P et al (2003) Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 29:1696\u20131702","journal-title":"Intensive Care Med"},{"key":"9002_CR113","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1378\/chest.128.1.288","volume":"128","author":"D Jefic","year":"2005","unstructured":"Jefic D, Lee J, Jefic D, Savoy-Moore R, Rosman H (2005) Utility of B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide in evaluation of respiratory failure in critically ill patients. Chest 128:288\u2013295","journal-title":"Chest"},{"key":"9002_CR114","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1097\/01.CCM.0000229144.97624.90","volume":"34","author":"A Rudiger","year":"2006","unstructured":"Rudiger A, Gasser S, Fischler M et al (2006) Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med 34:2140\u20132144","journal-title":"Crit Care Med"},{"key":"9002_CR115","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1399-6576.2006.00963.x","volume":"50","author":"LB Thierry","year":"2006","unstructured":"Thierry LB, Brocas E, Van de Louw A et al (2006) B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress. Acta Anaesthesiol Scand 50:340\u2013347","journal-title":"Acta Anaesthesiol Scand"},{"key":"9002_CR116","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1054\/jcaf.2001.23355","volume":"7","author":"R Kazanegra","year":"2001","unstructured":"Kazanegra R, Cheng V, Garcia A et al (2001) A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail 7:21\u201329","journal-title":"J Card Fail"},{"key":"9002_CR117","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ahj.2004.05.051","volume":"149","author":"J O\u2019Neill","year":"2005","unstructured":"O\u2019Neill J, Bott-Silverman C, McRae AI, Troughton R, Starling R, Young J (2005) B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure. Am Heart J 149:363\u2013369","journal-title":"Am Heart J"},{"key":"9002_CR118","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.jacc.2005.01.046","volume":"45","author":"PR Forfia","year":"2005","unstructured":"Forfia PR, Watkins SP, Rame JE et al (2005) Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit. J Am Coll Cardiol 45:1667\u20131671","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR119","doi-asserted-by":"crossref","first-page":"984e1","DOI":"10.1016\/j.ahj.2005.07.031","volume":"150","author":"KB James","year":"2005","unstructured":"James KB, Troughton RW, Feldschuh J et al (2005) Blood volume and brain natriuretic peptide in congestive heart failure: a pilot study. Am Heart J 150:984.e1\u2013984.e6","journal-title":"Am Heart J"},{"key":"9002_CR120","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1161\/01.CIR.0000143547.55093.17","volume":"110","author":"M Shlipak","year":"2004","unstructured":"Shlipak M, Massie B (2004) The clinical challenge of cardiorenal syndrome. Circulation 110:1514\u20131517","journal-title":"Circulation"},{"key":"9002_CR121","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1053\/ajkd.2003.50118","volume":"41","author":"P McCullough","year":"2003","unstructured":"McCullough P, Duc P, Omland T et al (2003) B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly multinational study. Am J Kid Dis 41:571\u2013579","journal-title":"Am J Kid Dis"},{"key":"9002_CR122","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1523-1755.2005.00079.x","volume":"67","author":"C Mueller","year":"2005","unstructured":"Mueller C, Laule-Kilian K, Scholer A et al (2005) B-type natriuretic peptide for acute dyspnea in patients with kidney disease: insights from a randomized comparison. Kidney Int 67:278\u2013284","journal-title":"Kidney Int"},{"key":"9002_CR123","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0272-6386(04)00812-1","volume":"44","author":"Y Takami","year":"2004","unstructured":"Takami Y, Horio T, Iwashima Y et al (2004) Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. Am J Kid Dis 44:420\u2013428","journal-title":"Am J Kid Dis"},{"key":"9002_CR124","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ajh.20456","volume":"80","author":"A Wu","year":"2005","unstructured":"Wu A, Omland T, Knudsen C et al (2005) Relationship of B-type natriuretic peptide and anemia in patients with and without heart failure: a substudy from the Breathing Not Properly (BNP) multinational study. Am J Hematol 80:174\u2013180","journal-title":"Am J Hematol"},{"key":"9002_CR125","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1053\/j.ajkd.2005.06.017","volume":"46","author":"S Vickery","year":"2005","unstructured":"Vickery S, Price C, John I et al (2005) B-type natriuretic peptide and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy. Am J Kid Dis 46:610\u2013620","journal-title":"Am J Kid Dis"},{"key":"9002_CR126","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1023\/A:1026195332025","volume":"8","author":"P McCullough","year":"2003","unstructured":"McCullough P, Sandberg K (2003) B-type natriuretic peptide and renal disease. Heart Fail Rev 8:355\u2013358","journal-title":"Heart Fail Rev"},{"key":"9002_CR127","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jacc.2005.08.051","volume":"47","author":"S Anwaruddin","year":"2006","unstructured":"Anwaruddin S, Lloyd-Jones D, Baggish A et al (2006) Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement. J Am Coll Cardiol 47:91\u201397","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR128","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jacc.2005.10.038","volume":"47","author":"T Tsutamoto","year":"2006","unstructured":"Tsutamoto T, Wada A, Sakai H et al (2006) Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. J Am Coll Cardiol 47:582\u2013586","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00004872-200501000-00006","volume":"23","author":"H Dastoor","year":"2005","unstructured":"Dastoor H, Bernieh B, Boobes Y et al (2005) Plasma BNP in patients on maintenance hemodialysis: a guide to management? J Hypertens 23:23\u201328","journal-title":"J Hypertens"},{"key":"9002_CR130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0002-9149(68)90244-0","volume":"22","author":"J Genest","year":"1968","unstructured":"Genest J, Granger P, de Champlain J, Boucher R (1968) Endocrine factors in congestive heart failure. Am J Cardiol 22:35\u201342","journal-title":"Am J Cardiol"},{"key":"9002_CR131","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1161\/01.CIR.0000109205.35813.8E","volume":"108","author":"M Packer","year":"2003","unstructured":"Packer M (2003) Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure. Circulation 108:2950\u20132953","journal-title":"Circulation"},{"key":"9002_CR132","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacc.2005.10.011","volume":"47","author":"A Maisel","year":"2006","unstructured":"Maisel A (2006) The coming of age of natriuretic peptides: the emperor does have clothes! J Am Coll Cardiol 47:61\u201364","journal-title":"J Am Coll Cardiol"},{"key":"9002_CR133","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7326\/ACPJC-2006-144-2-048","volume":"144","author":"JN Cohn","year":"2006","unstructured":"Cohn JN (2006) B-type natriuretic peptide had reduced specificity for diagnosing heart failure and dyspnea with atrial fibrillation in the emergency department. [Comment]. ACP J Club 144:48","journal-title":"ACP J Club"},{"key":"9002_CR134","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM200007273430403","volume":"343","author":"W Colucci","year":"2000","unstructured":"Colucci W, Elkayam U, Horton D et al (2000) Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med 343:246\u2013253","journal-title":"N Engl J Med"},{"key":"9002_CR135","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1067\/mhj.2002.125620","volume":"144","author":"A Burger","year":"2002","unstructured":"Burger A, Horton D, LeJemtel T et al (2002) Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Am Heart J 144:1102\u20131108","journal-title":"Am Heart J"},{"key":"9002_CR136","first-page":"1531","volume":"287","author":"Publication committee for the VMAC investigators","year":"2002","unstructured":"Publication committee for the VMAC investigators (2002) Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 287:1531\u20131540","journal-title":"JAMA"},{"key":"9002_CR137","doi-asserted-by":"crossref","first-page":"17442","DOI":"10.1073\/pnas.0508782102","volume":"102","author":"A Hawkridge","year":"2005","unstructured":"Hawkridge A, Heublein D, Bergen H, Cataliotti A, Burnett J, Muddiman D (2005) Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc Natl Acad Sci 102:17442\u201317447","journal-title":"Proc Natl Acad Sci"},{"key":"9002_CR138","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0140-6736(00)02060-2","volume":"355","author":"R Troughton","year":"2000","unstructured":"Troughton R, Frampton C, Yandle T, Espiner E, Nicholls M, Richards A (2000) Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355:1126\u20131130","journal-title":"Lancet"},{"key":"9002_CR139","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01.hco.0000161832.04952.6a","volume":"20","author":"D Lee","year":"2005","unstructured":"Lee D, Vasan R (2005) Novel markers for heart failure diagnosis and prognosis. Curr Opin Cardiol 20:201\u2013210","journal-title":"Curr Opin Cardiol"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-007-9002-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-007-9002-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-007-9002-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-007-9002-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T02:10:35Z","timestamp":1652839835000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-007-9002-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":139,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["9002"],"URL":"https:\/\/doi.org\/10.1007\/s10741-007-9002-9","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"15 January 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}